ArticleDiabetes technology & therapeutics2019

Adoption of New Glucose-Lowering Medications in the U.S.-The Case of SGLT2 Inhibitors: Nationwide Cohort Study.

Rozalina G McCoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.